PGC1α protects against hepatic steatosis and insulin resistance via enhancing IL10‐mediated anti‐inflammatory response-Reference-Cited by-同舟云学术

PGC1α protects against hepatic steatosis and insulin resistance via enhancing IL10‐mediated anti‐inflammatory response

Published:2020-07-07 Issue:8 Volume:34 Page:10751-10761
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Wan Xingyong¹,Zhu Xudong²,Wang Hu²,Feng Ye¹,Zhou Weihua¹³,Liu Peihao¹,Shen Weiyan⁴,Zhang Lingling²,Liu Leiming⁴,Li Tangliang²,Diao Daojun⁴,Yang Fan⁴,Zhao Qi⁵,Chen Li⁵,Ren Jian⁵,Yan Sheng⁶,Li Jing⁷,Yu Chaohui¹,Ju Zhenyu²⁴

Affiliation:

1. Department of Gastroenterology, the First Affiliated Hospital, School of Medicine Zhejiang University Hangzhou China

2. Institute of Ageing Research, School of Medicine Hangzhou Normal University Hangzhou China

3. Department of Pathology Sanmen People's Hospital Taizhou China

4. Key Laboratory of Regenerative Medicine of Ministry of Education Institute of Aging and Regenerative Medicine Jinan University Guangzhou China

5. Sun Yat‐sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine Guangzhou China

6. Department of Hepatobiliary Surgery, the Second Affiliated Hospital, School of Medicine Zhejiang University Hangzhou China

7. Department of Endocrinology, Beijing Chao‐yang Hospital Capital Medical University Beijing China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.201902476R

Reference38 articles.

1. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes